D.E. Shaw & Co’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,779
Closed -$779K 3221
2024
Q4
$779K Sell
21,779
-19,119
-47% -$683K ﹤0.01% 2222
2024
Q3
$1.93M Sell
40,898
-17,725
-30% -$838K ﹤0.01% 1815
2024
Q2
$2.95M Buy
58,623
+9,718
+20% +$488K ﹤0.01% 1537
2024
Q1
$5.48M Buy
48,905
+22,210
+83% +$2.49M ﹤0.01% 1238
2023
Q4
$1.55M Buy
26,695
+23,984
+885% +$1.39M ﹤0.01% 1861
2023
Q3
$86.1K Sell
2,711
-36,719
-93% -$1.17M ﹤0.01% 2686
2023
Q2
$3.24M Sell
39,430
-32,814
-45% -$2.7M ﹤0.01% 1486
2023
Q1
$7.42M Sell
72,244
-21,194
-23% -$2.18M 0.01% 1111
2022
Q4
$13.7M Sell
93,438
-11,531
-11% -$1.69M 0.02% 783
2022
Q3
$17.7M Buy
104,969
+25,852
+33% +$4.37M 0.02% 613
2022
Q2
$9.14M Sell
79,117
-4,518
-5% -$522K 0.01% 1055
2022
Q1
$8.34M Buy
83,635
+57,839
+224% +$5.77M 0.01% 1250
2021
Q4
$4.01M Buy
25,796
+23,852
+1,227% +$3.71M ﹤0.01% 1872
2021
Q3
$458K Buy
1,944
+341
+21% +$80.3K ﹤0.01% 2885
2021
Q2
$544K Sell
1,603
-4,560
-74% -$1.55M ﹤0.01% 2856
2021
Q1
$2.49M Sell
6,163
-15,592
-72% -$6.31M ﹤0.01% 1729
2020
Q4
$14.5M Sell
21,755
-8,314
-28% -$5.53M 0.01% 822
2020
Q3
$14M Sell
30,069
-10,969
-27% -$5.11M 0.01% 748
2020
Q2
$24M Buy
41,038
+40,112
+4,332% +$23.5M 0.03% 511
2020
Q1
$135K Sell
926
-5,000
-84% -$729K ﹤0.01% 2520
2019
Q4
$848K Sell
5,926
-3,737
-39% -$535K ﹤0.01% 1976
2019
Q3
$382K Sell
9,663
-130
-1% -$5.14K ﹤0.01% 2174
2019
Q2
$991K Buy
9,793
+5,209
+114% +$527K ﹤0.01% 1890
2019
Q1
$603K Buy
+4,584
New +$603K ﹤0.01% 2052
2018
Q1
Sell
-681
Closed -$280K 2596
2017
Q4
$280K Buy
+681
New +$280K ﹤0.01% 2295